FOLLICLE-STIMULATING HORMONE RECEPTOR IS EXPRESSED BY MOST OVARIAN CANCER SUBTYPES AND IS A SAFE AND EFFECTIVE IMMUNOTHERAPEUTIC TARGET

PURPOSE: Define the safety and effectiveness of T-cells re-directed against Follicle-Stimulating Hormone Receptor (FSHR)-expressing ovarian cancer cells. EXPERIMENTAL DESIGN: FSHR expression was determined by Western-blot, immunohistochemistry and Q-PCR in 77 human ovarian cancer specimens from 6 di...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Perales-Puchalt, Alfredo, Svoronos, Nikolaos, Rutkowski, Melanie R, Allegrezza, Michael J, Tesone, Amelia J, Payne, Kyle K, Wickramasinghe, Jayamanna, Nguyen, Jenny M, O'Brien, Shane W, Gumireddy, Kiranmai, Huang, Qihong, Cadungog, Mark G., Connolly, Denise C, Tchou, Julia, Curiel, Tyler J, Conejo-Garcia, Jose R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5241180/
https://ncbi.nlm.nih.gov/pubmed/27435394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-0492
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados